AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Losec loses market share in US.

Asia Africa Intelligence Wire

| April 01, 2003 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From Chemical Business NewsBase - Dagens Industri)

In the weekend ending 21 Mar 2003 Losec's share of the US market for newly prescribed proton pump inhibitors fell from 10.1% to 9.6%. At the same time the market share of generic versions of omeprazole ...

Related articles from newspapers, magazines, journals, and more
ASTRA ZENECA DEBUTS IN CHINA'S OTC DRUG AREA.
News wire article from: AsiaPulse News April 13, 2005 700+ words
...SHANGHAI, April 13 Asia Pulse - World pharmaceutical giant Astra Zeneca has ben approved to put its Losec MUPS (omeprazole) on...predicted to sustain in the coming ten years. At present, the market share of digestive drugs accounts for about 10 per cent of China...
Astra Zeneca poised to swoop for pounds 600m rival.(News)
Newspaper article from: The Journal (Newcastle, England) May 15, 2006 700+ words
Pharmaceuticals firm Astra Zeneca is this week expected to announce...closed at 796.5p on Friday. Astra Zeneca, which is reportedly being advised...Under the terms of the agreement, Astra Zeneca paid pounds 75m for a 19.9...
Astra-Zeneca receives non-approvable letter for Casodex.(Brief Article)
Newspaper article from: Nordic Business Report June 24, 2002 700+ words
...NORDIC BUSINESS REPORT-24 June 2002-Astra-Zeneca receives non-approvable letter for...COMMUNICATIONS LTD http://www.m2.com Astra-Zeneca, a Swedish-British pharmaceuticals...Industri, a Swedish business newspaper. Astra-Zeneca has said that the decision was somewhat...
ICI INDIA TO GIVE FIRST PREFERENCE TO TECH PARTNER ASTRA ZENECA.
News wire article from: AsiaPulse News February 22, 2001 700+ words
...preference to its technological partner Astra Zeneca while divesting its pharmaceutical business. "Astra Zeneca would obviously be the preferred party...the heels of controversy following Astra Zeneca's acquisition of 25.75 percent...
Drugs firm defies gloom; Astra Zeneca sales up despite US setback.(Business)
Newspaper article from: Daily Post (Liverpool, England) October 22, 2004 700+ words
...CHESHIRE-BASED pharmaceuticals giant Astra Zeneca overcame dismay at regulatory glitches...7% hike in third-quarter sales. Astra Zeneca said it achieved turnover of $5. 27bn...have been dispensed around the world, Astra Zeneca said. The Anglo-Swedish company needs...
New drugs boost Astra Zeneca sales to pounds 5. 29bn.(Business)
Newspaper article from: Daily Post (Liverpool, England) July 23, 2004 700+ words
DRUGS giant Astra Zeneca, which has a major production base in Cheshire, posted a sharp...world pharmaceutical market is becoming increasingly challenging, Astra Zeneca is well placed with its new products to deliver good growth...
Dr Reddy's Lab wins litigation against Astra Zeneca's in US.
News wire article from: PTI - The Press Trust of India Ltd. March 12, 2009 700+ words
Dr Reddy's Lab wins litigation against Astra Zeneca's in US New Delhi, Mar 12 (PTI) Drugmaker Dr Reddy...Omeprazole for which it was fighting a litigation against Astra Zeneca's Prilosec. "We are very pleased with the favourable...
The FDA called a full-page ad defending Astra-Zeneca's Crestor "false and...
Magazine article from: Medical Marketing & Media February 1, 2005 700+ words
The FDA called a full-page ad defending Astra-Zeneca's Crestor "false and misleading" because of lingering concerns about the drug's safety. In a recent letter to Astra-Zeneca, federal regulators said the ad's claims that "the FDA...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA